Clinical trial
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for…
NCT00399061 · Innovative Medical, Industry · Completed
Key facts
| NCT number | NCT00399061 |
|---|---|
| Title | Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms |
| Official title | Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms |
| Lead sponsor | Innovative Medical, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dry Eye |
| Intervention type | Drug |
| Interventions | Systane, Optive, Restasis |
| Enrollment | 55 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 14, 2006 |
| Last update posted | Sep 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: